Your privacy is important to us. Cookies are very small text files that are stored on your computer when you visit a website. We use cookies and other tracking technologies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website. You can check our privacy policy page for more information.
In an increasingly competitive global environment, it is critical that the U.S. strengthen its standing in science, technology, engineering and math (STEM) education to stay ahead of other countries, like China and Singapore, in order to continue create more high-wage research and development (R&D) and advanced manufacturing jobs in the U.S. and sustain and grow the economic contributions of R&D-intensive industries like the innovative biopharmaceutical sector. The U.S. biopharmaceutical sector is the envy of the world supporting a total of nearly 4.5 million jobs across the economy, and contributing $1.2 trillion in economic output when direct and indirect effects are considered in the U.S. alone.
The U.S. currently faces a growing gap in STEM skills compared to countries such as Japan, China, and parts of Europe, which are making substantial public investments in STEM education and other key areas of competitiveness, including growing their R&D, manufacturing, and other infrastructure investments. As an industry rooted in science and innovation, the biopharmaceutical industry is particularly concerned about the current shortage of highly-skilled workers in the U.S., a gap that is expected to grow substantially over the next decade leading individual biopharmaceutical companies to deepen their commitment to improving the state of STEM education at all levels in the U.S.
Enhancing Today’s STEM Workforce to Ensure Tomorrow’s New Medicines, reveals how innovative biopharmaceutical companies and their foundations are partnering with colleges and universities to foster the next generation of STEM workers. According to the report, biopharmaceutical companies and their foundations have partnered with 53 individual colleges and universities in support of 75 educational programs emphasizing hands-on, experiential learning through a focus on industry-relevant curricula. These partnerships are happening at all levels of the postsecondary pipeline from various certification and associate’s programs though master’s and doctoral programs and worker training programs.
Research finds strong linkages between STEM-intensive industries and desirable innovation and economic outcomes, including the creation of high-growth, high-quality jobs with bright career prospects. The innovative biopharmaceutical industry demonstrates these characteristics by leveraging STEM talent throughout every aspect of a medicine’s life cycle.
This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.